The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Gut–Liver Axis in Alcoholic Liver Disease
Open accessAbstract
Alcoholic liver disease (ALD) has been among the leading causes of cirrhosis and liver-related death worldwide for decades. Early discoveries in alcoholic liver disease identified increased levels of bacterial endotoxin in the portal circulation, suggesting a role for gut-derived toxins in ALD. Indeed, alcohol consumption can disrupt the intestinal epithelial barrier and result in increased gut permeability that increasingly is recognized as a major factor in ALD. Bacterial endotoxin, lipopolysaccharide, is a prototypic microbe-derived inflammatory signal that contributes to inflammation in ALD through activation of the Toll-like receptor 4. Recent studies also have shown that alcohol consumption is associated with alterations in the gut microbiome, and the dysbalance of pathogenic and commensal organisms in the intestinal microbiome may contribute to the abnormal gut-liver axis in ALD. Indeed, bacterial decontamination improves ALD both in human and animal models. This short review summarizes recent findings and highlights emerging trends in the gut-liver axis relevant to ALD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the gut-liver axis has been shown to play an important role in the development of ALD.5,6”
From Opposite regulation of intestinal and intrahepatic CD8 + T cells controls alcohol-associated liver disease progression (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“A number of functional studies have shown a key contribution of the gut-microbiota–TLR4 axis to ALD45:”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,986
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,907
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346
Bile acids and the gut microbiome
Ridlon, J. M., Kang, D. J., Hylemon, P. B., & Bajaj, J. S. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000057 · Cited by 1,329
Rifaximin Treatment in Hepatic Encephalopathy
Bass, N. M., Mullen, K. D., Sanyal, A., Poordad, F., Neff, G., Leevy, C. B., Sigal, S., Sheikh, M. Y., Beavers, K., Frederick, T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907893 · Cited by 1,300
Interactions Between the Intestinal Microbiome and Liver Diseases
Schnabl, B., & Brenner, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.020 · Cited by 971
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 754
Fujimoto, Y., Kaji, K., Nishimura, N., Enomoto, M., Murata, K., Takeda, S., Takaya, H., Kawaratani, H., Moriya, K., Namisaki, T., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i48.8323 · Cited by 29
Xu, L., Li, W., Chen, S., Deng, X.-W., Deng, W.-F., Liu, G., Chen, Y., & Cao, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1053718 · Cited by 29
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease
Scarlata, G. G. M., Colaci, C., Scarcella, M., Dallio, M., Federico, A., Boccuto, L., & Abenavoli, L. (2024) · Diseases · doi:10.3390/diseases12040069 · Cited by 27
Dong, Y., Zhang, Y.-P., Jiang, X., Xie, Z.-Y., Li, B., Jiang, N.-H., Chen, S., & Lv, G. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155816 · Cited by 28
Zhang, L., Zhang, Z., Liu, B., Jin, Y., Tian, Y., Xin, Y., & Duan, Z. (2017) · Molecular Medicine · doi:10.2119/molmed.2017.00078 · Cited by 28
Ren, Y., Geng, Y., Chen, H., Lu, Z., Shi, J., & Xu, Z. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.11.051 · Cited by 28
Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease
Kwong, E. K., & Puri, P. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2020.02.18 · Cited by 28
The Microbiome–Gut–Brain Axis, a Potential Therapeutic Target for Substance-Related Disorders
Fu, X., Chen, T., Cai, J., Liu, B., Zeng, Y., & Zhang, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.738401 · Cited by 29
Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH
Welch, R. D., Billon, C., Losby, M., Bedia‐Diaz, G., Fang, Y., Avdagic, A., Elgendy, B., Burris, T. P., & Griffett, K. (2022) · Metabolites · doi:10.3390/metabo12030238 · Cited by 28
Warner, J. B., Guenthner, S. C., Hardesty, J., McClain, C. J., Warner, D. R., & Kirpich, I. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i36.5280 · Cited by 31
Metabolomics Reveals Gut Microbiota Contribute to PPARα Deficiency-Induced Alcoholic Liver Injury
Zhang, T., Bao, L., Zhao, Q., Wu, Z. E., Dai, M., Rao, Q., & Li, F. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00093 · Cited by 28
Kc, R., Voigt, R. M., Li, X., Forsyth, C. B., Ellman, M. B., Summa, K. C., Turek, F. W., Keshavarzian, A., Kim, J., & Im, H. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39090 · Cited by 28
Role of spleen tyrosine kinase in liver diseases
Kurniawan, D. W., Storm, G., Prakash, J., & Bansal, R. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i10.1005 · Cited by 29
Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease
Giuli, L., Maestri, M., Santopaolo, F., Pompili, M., & Ponziani, F. R. (2023) · Metabolites · doi:10.3390/metabo13060772 · Cited by 30
Advancement of Engineered Bacteria for Orally Delivered Therapeutics
Guo, P., Wang, S., Yue, H., Zhang, X., Ma, G., Li, X., & Wei, W. (2023) · Small · doi:10.1002/smll.202302702 · Cited by 27
Zhu, L., Cao, F., Hu, Z., Zhou, Y., Guo, T., Yan, S., Xie, Q., Xia, X., Yuan, H., Li, G., et al. (2024) · Nutrients · doi:10.3390/nu16050694 · Cited by 29
The gut-liver axis in fatty liver disease: role played by natural products
Ming, Z., Ruishi, X., Linyi, X., Yonggang, Y., Haoming, L., & Lan, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1365294 · Cited by 27
Lowe, P., Cho, Y., Tornai, D., Çoban, Ş., Catalano, D. E., & Szabó, G. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14272 · Cited by 27
Microbiota and viral hepatitis: State of the art of a complex matter
Milošević, I., Russo, E., Vujović, A., Barac, A. M., Stevanović, O., Gitto, S., & Amedei, A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i33.5488 · Cited by 31
Overview of the microbiota in the gut-liver axis in viral B and C hepatitis
Neag, M. A., Mitre, A. O., Cătinean, A., & Buzoianu, A. D. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i43.7446 · Cited by 27
Advancements in the Alcohol-Associated Liver Disease Model
Zhu, L., Li, H.-D., Xu, J., Li, J., Cheng, M., Meng, X., Huang, C., & Li, J. (2022) · Biomolecules · doi:10.3390/biom12081035 · Cited by 30
Jiang, Y., Zhong, M., Zhan, H., Tao, X., Zhang, Y., Mao, J., Zhao, G., & Gao, B. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115589 · Cited by 27
Li, J.-S., Fan, L.-Y., Yuan, M.-D., & Xing, M. (2019) · Current Medical Science · doi:10.1007/s11596-019-2069-4 · Cited by 27
Extracellular vesicles participate in macrophage-involved immune responses under liver diseases
Shao, J., Li, S., Liu, Y., & Zheng, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117094 · Cited by 25
Sang, L.-X., Kang, K., Sun, Y., Li, Y.-L., & Chang, B. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107572 · Cited by 26
Matye, D. J., Li, Y., Chen, C., Chao, X., Wang, H., Ni, H., Ding, W., & Li, T. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14619 · Cited by 25
Pre-hatching and post-hatching environmental factors related to epigenetic mechanisms in poultry
Dunisławska, A., Pietrzak, E., Wishna-Kadawarage, R. N., Bełdowska, A., & Siwek, M. Z. (2021) · Journal of Animal Science · doi:10.1093/jas/skab370 · Cited by 30
Tan, J., Zhang, J., Wang, M., Wang, Y., Dong, M., Ma, X., Sun, B., Liu, S., Zhao, Z., Chen, L., et al. (2022) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2021.12.017 · Cited by 26
Effects of alcohol withdrawal on monocyte subset defects in chronic alcohol users
Donnadieu‐Rigole, H., Mura, T., Portalès, P., Duroux-Richard, I., Bouthier, M., Eliaou, J., Perney, P., & Apparailly, F. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0216-060rr · Cited by 26
Meyer, S. K., Probert, P. M. E., Lakey, A. F., Axon, A., Leitch, A. C., Williams, F. M., Jowsey, P. A., Blain, P. G., Kass, G. E. N., & Wright, M. C. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.03.024 · Cited by 26
Szabó, G. (2018) · Hepatology · doi:10.1002/hep.30055 · Cited by 26
Zhang, R., Chen, Y., Zhang, J., & Liu, J. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002456 · Cited by 28
Li, X., Zhu, R., Liu, Q., Sun, H., Sheng, H., & Zhu, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136691 · Cited by 26
Jian, E., Wang, M., Zhang, Z., Heng, Y., Zhang, C., Chen, Q., Yu, X., Zhu, Y., & Cai, P. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1634803 · Cited by 34
Emerging role of circadian clock disruption in alcohol-induced liver disease
Bailey, S. M. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00010.2018 · Cited by 27
Lee, M. R., Abshire, K. M., Farokhnia, M., Akhlaghi, F., & Leggio, L. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108771 · Cited by 25
Yang, Y. M., Zhou, Z., Liu, Y., Xu, X., Xu, Y., Zhou, W., Chen, S., & Ma, D. (2022) · Foods · doi:10.3390/foods11111537 · Cited by 26
Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease
Hyun, J. Y., Kim, S. K., Yoon, S. J., Lee, S. B., Jeong, J., Gupta, H., Sharma, S. P., Oh, K., Won, S., Kwon, G.-H., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158749 · Cited by 25
Liu, H., Meng, W., Zhao, D., Ma, Z., Zhang, W., Chen, Z., Li, Z., & Zhao, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1074286 · Cited by 25
Li, Y., Liang, X., Lyu, Y., Wang, K., Han, L., Wang, Y., Sun, J., & Chi, C. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.07.014 · Cited by 25
Xin, B., Cui, Y., Wang, Y., Wang, L., Yin, J., Zhang, L., Pang, H., Zhang, H., & Wang, R. (2017) · Oncology Letters · doi:10.3892/ol.2017.6800 · Cited by 25
Irwin, C., Mienie, L. J., Wevers, R. A., Mason, S., Westerhuis, J. A., van Reenen, M., & Reinecke, C. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-24128-1 · Cited by 25
Kim, B. K., Lee, I. O., Tan, P. L., Eor, J. Y., Hwang, J. K., & Kim, S. H. (2017) · Europe PMC (PubMed Central) · doi:10.5851/kosfa.2017.37.6.931 · Cited by 25
Alcoholic liver disease-from steatosis to cirrhosis - a biochemistry approach
Cioarca-Nedelcu, R., Atanasiu, V., & Stoian, I. A.-M. (2021) · Journal of Medicine and Life · doi:10.25122/jml-2021-0081 · Cited by 24
The Translational Bridge between Inflammation and Hepatocarcinogenesis
Gufler, S., Seeboeck, R., Schatz, C., & Haybaeck, J. (2022) · Cells · doi:10.3390/cells11030533 · Cited by 26
Liu, Z., Xu, X., Shen, Y., Hao, Y., Cui, W., Li, W., Zhang, X., Lv, H., Li, X., Hou, Y., et al. (2022) · Cell Proliferation · doi:10.1111/cpr.13245 · Cited by 24
Wu, L., Zhou, K., Yang, Z., Li, J., Chen, G., Wu, Q., Lv, X., Hu, W., Rao, P., Ai, L., et al. (2022) · Foods · doi:10.3390/foods11193048 · Cited by 24
Experimental models of fatty liver diseases: Status and appraisal
Wang, H., Shen, H., Seo, W., & Hwang, S. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000200 · Cited by 26
Dunisławska, A., Sławińska, A., & Siwek, M. Z. (2020) · Genes · doi:10.3390/genes11050579 · Cited by 23
Shibamoto, A., Kaji, K., Nishimura, N., Kubo, T., Iwai, S., Tomooka, F., Suzuki, J., Tsuji, Y., Fujinaga, Y., Kawaratani, H., et al. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109450 · Cited by 23
Li, W., Pan, Y., Yu, G., Zhu, Y., Jin, H., Gu, Y., Li, C., Wang, Y., Lin, J., Chen, Y., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1355225 · Cited by 23
Ji, M., Fang, C., Jia, W. P., Du, H., & Xu, Y. (2021) · Food & Function · doi:10.1039/d0fo03028g · Cited by 24
Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease
Ezquer, F. E. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i1.24 · Cited by 23
Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases
Wu, M., Li, K., Wu, J., Ding, X., Ma, X., Wang, W., & Xiao, W. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2024.107571 · Cited by 23
Treatment of severe alcoholic hepatitis: A systematic review
Melkebeke, L. V., Korf, H., Tsochatzis, E. A., der Merwe, V., Nevens, F., & Verbeek, J. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.06.011 · Cited by 22
Fang, C., Zhou, Q., Liu, Q., Jia, W. P., & Xu, Y. (2021) · Food & Function · doi:10.1039/d1fo02892h · Cited by 22
Chen, J., Wu, S., Wu, R., Ai, H., Lu, X., Wang, J., Luo, Y., Li, L., & Cao, J. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108962 · Cited by 22
Berbamine ameliorates ethanol-induced liver injury by inhibition of hepatic inflammation in mice
Liu, X., Guan-Nan, C. H. E. N., Guo-Ming, D. U., Pan, Y., Song, W., Jiang, T., & Liu, H. (2020) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(20)30020-0 · Cited by 21
Emerging Pharmacotherapies in Alcohol-Associated Hepatitis
Wakil, A., Niazi, M. A., Meybodi, M. A., & Pyrsopoulos, N. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.06.012 · Cited by 21
Goblet cell‐associated antigen passage: A gatekeeper of the intestinal immune system
Zhang, X., Chen, X., Wang, Z., Meng, X., Hoffmann‐Sommergruber, K., Cavallari, N., Wu, Y., Gao, J., Li, X., & Chen, H. (2023) · Immunology · doi:10.1111/imm.13648 · Cited by 21
Cui, Y., Jing, C., Yue, Y., Ning, M., Chen, H., Yuan, Y., & Yue, T. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300301 · Cited by 22
Alcoholic Hepatitis: Risk Factors, Pathogenesis, and Approach to Treatment
Yeluru, A., Cuthbert, J. A., Casey, L. C., & Mitchell, M. C. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12956 · Cited by 21
Community-Metabolome Correlations of Gut Microbiota from Child-Turcotte-Pugh of A and B Patients
Wei, X., Jiang, S., Zhao, X., Li, H., Lin, W., Li, B., Lü, J., Sun, Y., & Yuan, J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01856 · Cited by 21
Abnormal Gut Microbiota Metabolism Specific for Liver Cirrhosis
Wei, X., Zhao, J., Jia, X., Zhao, X., Li, H., Lin, W., Feng, R., & Yuan, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03051 · Cited by 21
Han, X., Liu, J., Bai, Y., Hang, A., Lu, T., & Mao, C. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104488 · Cited by 21
Infection in Severe Alcoholic Hepatitis: Yet Another Piece in the Puzzle
Singal, A. K., Shah, V. H., & Kamath, P. S. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.030 · Cited by 21
Reinold, J., Farahpour, F., Schoerding, A.-K., Fehring, C., Dolff, S., Konik, M., Korth, J., van Baal, L., Buer, J., Witzke, O., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.848650 · Cited by 20
Yang, F., Li, X., Sun, J. Y., Pang, X., Sun, Q., & Lu, Y. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2455954 · Cited by 22
Boye, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i1.50 · Cited by 20
Kovalic, A. J., Cholankeril, G. T., & Satapathy, S. K. (2019) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.08.09 · Cited by 20
McMahan, R. H., Najarro, K. M., Mullen, J. E., Paul, M. T., Orlicky, D. J., Hulsebus, H. J., & Kovacs, E. J. (2021) · Immunity & Ageing · doi:10.1186/s12979-021-00247-8 · Cited by 20
Maccioni, L., Guan, Y., Kim, M., Parra, M. A., Peiffer, B., Fu, Y., Wang, Y., Lin, Y.-H., Mackowiak, B., Feng, D., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-334412 · Cited by 21
Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease
Li, W., Gao, W., Yan, Q. S., Yang, L., Zhu, Q., & Chu, H. (2024) · Biomedicines · doi:10.3390/biomedicines13010074 · Cited by 19
Liu, J., Wang, Y., Zhang, G., Liu, L., & Peng, X. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.753034 · Cited by 21
Dietary camellia seed oil attenuates liver injury in mice chronically exposed to alcohol
Guo, R., Zhu, J., Chen, L., Li, J., Ding, Q., Han, Q., Zheng, W., & Li, S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1026740 · Cited by 19
Zogona, D., Zongo, A. W., Elkhedir, A. E. E., Salah, M., Tao, M., Li, R., Wu, T., & Xu, X. (2022) · Food & Function · doi:10.1039/d2fo03245g · Cited by 21
Current and future treatment for alcoholic‐related liver diseases
Yoon, E. L., & Kim, W. K. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16257 · Cited by 19
Baek, S.-M., Kim, T., Lee, Y.-J., Lee, S.-W., Yim, J.-H., Kim, W. J., Kim, H.-Y., Kang, K., Kim, S., Park, S., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115342 · Cited by 20
Human neutrophil peptide-1 promotes alcohol-induced hepatic fibrosis and hepatocyte apoptosis
Ibusuki, R., Uto, H., Oda, K., Ohshige, A., Tabu, K., Mawatari, S., Kumagai, K., Kanmura, S., Tamai, T., Moriuchi, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174913 · Cited by 19
Noncoding RNAs in alcoholic liver disease
Li, H.-D., Du, X., Huang, H., Chen, X., Yang, Y., Huang, C. Z., Meng, X., & Li, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28229 · Cited by 19
The Role of Intestinal Fungi and Its Metabolites in Chronic Liver Diseases
You, N., Zhuo, L., Zhou, J., Song, Y., & Shi, J. (2019) · Gut and Liver · doi:10.5009/gnl18579 · Cited by 19
Pritchard, M. T., & McCracken, J. M. (2015) · Current Drug Targets · doi:10.2174/1389450116666150825111439 · Cited by 19
Mitchell, M. C., & Szabó, G. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch26 · Cited by 19
Managing alcoholic liver disease
Shah, V. H. (2015) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2015.21.3.212 · Cited by 18
Acute on chronic liver failure in non-alcoholic fatty liver and alcohol associated liver disease
Singal, A. K., & Kamath, P. S. (2019) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.09.11 · Cited by 18
Wang, T., Wang, Z., Yang, Z., Cui, X., Liang, Y., Xu, Z., & Liu, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.722171 · Cited by 18
Interleukin-9 attenuates inflammatory response and hepatocyte apoptosis in alcoholic liver injury
Meng, H., Niu, R., You, H., Wang, L., Feng, R., Huang, C., & Li, J. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120180 · Cited by 18
The Gut Microbiome and Hepatocellular Carcinoma
Akkız, H. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-021-00748-1 · Cited by 18
The role of gut microbiota in infectious diseases
Cai, Y., Chen, L., Zhang, S., Zeng, L., & Zeng, G. (2022) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1551 · Cited by 18
Human Beta Defensin 2 Ameliorated Alcohol-Associated Liver Disease in Mice
Warner, J. B., Larsen, I., Hardesty, J., Song, Y., Warner, D. R., McClain, C. J., Sun, R., Deng, Z., Jensen, B. A. H., & Kirpich, I. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.812882 · Cited by 18
Xu, L., Zhang, Q.-Y., Chen, Y.-K., Chen, L., Zhang, K., Wang, Q., & Xie, X. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.120186 · Cited by 18
Cui, Y., Guo, P., Ning, M., Yuan, Y., Yuan, Y., & Yue, T. (2023) · Food & Function · doi:10.1039/d3fo01796f · Cited by 18
Jouve, M., Carpentier, R., Kraiem, S., Legrand, N., & Sobolewski, C. (2023) · Cancers · doi:10.3390/cancers15235557 · Cited by 18
Pharmacological chaperone therapies: Can aldehyde dehydrogenase activator make us healthier?
Dollé, L., & Gao, B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.011 · Cited by 18
Application of Impedance-Based Techniques in Hepatology Research
Morgan, K., Gamal, W., Samuel, K., Morley, S. D., Hayes, P. C., Bagnaninchi, P., & Plevris, J. N. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010050 · Cited by 18
Effect of procyanidins on lipid metabolism and inflammation in rats exposed to alcohol and iron
Lobo, A., Liu, Y., Song, Y., Liu, S., Zhang, R., Liang, H., & Xin, H. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04847 · Cited by 18
Diet-Regulating Microbiota and Host Immune System in Liver Disease
Eom, J. A., Kwon, G.-H., Kim, N. Y., Park, E. J., Won, S. M., Jeong, J., Ganesan, R., Gupta, H., Gebru, Y. A., Sharma, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126326 · Cited by 18
Liu, Y., Niu, G., Li, C., Guo, J., Song, J. M., Li, H., & Zhang, X. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.695019 · Cited by 19
Role of mechanistic target of rapamycin in autophagy and alcohol-associated liver disease
Chao, X., Williams, S. N., & Ding, W. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00281.2022 · Cited by 17
Zhou, Z., Pan, X., & Li, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1070208 · Cited by 19
Metadata
- Authors
- Szabo, G.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 148
- Issue
- 1
- Pages
- 30-36
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC4274189
- OpenAlex
- W2034801500
- Cited by
- 754
- References
- 81
- Citations by year
- 2026: 64 · 2025: 67 · 2024: 72 · 2023: 67 · 2022: 89 · 2021: 77 · 2020: 63 · 2019: 59 · 2018: 67 · 2017: 49 · 2016: 51 · 2015: 28
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA021907, AA017729, AA010744)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- alcoholic liver disease, gut-liver axis, bacterial endotoxin, lipopolysaccharide, intestinal permeability, intestinal epithelial barrier, TLR4, gut microbiota, bacterial decontamination, liver cirrhosis, inflammation
- MeSH terms
- Animals, Bacteria, Humans, Intestinal Mucosa, Intestines, Liver, Liver Diseases, Alcoholic, Permeability, Prognosis, Signal Transduction, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
